0001209191-18-008272.txt : 20180207 0001209191-18-008272.hdr.sgml : 20180207 20180207200609 ACCESSION NUMBER: 0001209191-18-008272 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180205 FILED AS OF DATE: 20180207 DATE AS OF CHANGE: 20180207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pope Todd CENTRAL INDEX KEY: 0001584367 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 18582485 MAIL ADDRESS: STREET 1: C/O TRANSENTERIX STREET 2: 635 DAVIS DRIVE, SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-05 0 0000876378 TRANSENTERIX INC. TRXC 0001584367 Pope Todd C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560 1 1 0 0 President and CEO Common Stock 2018-02-05 4 M 0 126556 0.00 A 356556 D Common Stock 2018-02-05 4 F 0 40484 1.53 D 316072 D Stock Option 1.39 2018-02-07 4 A 0 1403000 0.00 A 2028-02-07 Common Stock 1403000 1403000 D Restricted Stock Units 0.00 2018-02-07 4 A 0 312000 0.00 A Common Stock 312000 312000 D Restricted Stock Units 2018-02-05 4 M 0 40556 0.00 D Common Stock 40556 40555 D Restricted Stock Units 2018-02-05 4 M 0 33333 0.00 D Common Stock 33333 0 D Restricted Stock Units 2018-02-05 4 M 0 52667 0.00 D Common Stock 52667 105333 D This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan. Each restricted stock unit represents the right to receive one share of the Registrant's common stock. Forfeiture restrictions will lapse on the restricted stock units in three equal annual installments of 104,000 on each of February 4, 2019, 2020 and 2021, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. /s/ Joshua Weingard,as Attorney-in-Fact for Todd Pope 2018-02-07